How Will Bristol Myers Squibb Stock Trend Post Q4 Results?
- Monday, January 30, 2023, 7:15
- Market
- Add a comment
A decline in Revlimid sales will likely more than offset sales growth for Eliquis, Opdivo, and Reblozyl.
About the Author
admin123 has written 23400 stories on this site.
